Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trial.

Arjyal, A; Basnyat, B; Nhan, HT; Koirala, S; Giri, A; Joshi, N; Shakya, M; Pathak, KR; Mahat, SP; Prajapati, SP; +18 more... Adhikari, N; Thapa, R; Merson, L; Gajurel, D; Lamsal, K; Lamsal, D; Yadav, BK; Shah, G; Shrestha, P; Dongol, S; Karkey, A; Thompson, CN; Thieu, NT; Thanh, DP; Baker, S; Thwaites, GE; Wolbers, M; Dolecek, C; (2016) Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trial. The Lancet infectious diseases. ISSN 1473-3099 DOI: https://doi.org/10.1016/S1473-3099(15)00530-7

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S1473-3099(15)00530-7

Abstract

Share

Download

Filename: main.PMC4835582.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar